REGENXBIO Inc.RGNXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank25
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-161.20M
↓ 48% vs avg
Percentile
P25
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-108.69M
Historical baseline
PeriodValueYoY Change
TTM$-161.20M+30.9%
2024$-233.35M+13.0%
2023$-268.13M-2.0%
2022$-262.88M-264.3%
2021$159.98M+234.2%
2020$-119.23M+20.0%
2019$-149.00M-269.1%
2018$88.10M+216.1%
2017$-75.89M-16.1%
2016$-65.34M-